Bentham期刊
期刊
会议
图书
作者:Qiaoyue Zhang , Xia Zhang , Yanyan Liu ...
来源:[J].Current Pharmaceutical Analysis(IF 1.333), 2019, Vol.16 (1), pp.40-46Bentham
摘要:Background: Spinosin is one of the major bioactive constituents among the total flavonoidsin semen ziziphi spinosae, which has sedation and hypnosis actions.
作者:Muhammad Usman , Fariha Tanveer , Amber Ilyas ...
来源:[J].Current Proteomics(IF 0.828), 2019, Vol.17 (1), pp.51-58Bentham
摘要:Background: Oral squamous cell carcinoma (OSCC) is a major sub-type of oral cancer that shares 90% proportion of oral cavity cancers. It is declared as sixth most frequent cancer among all cancer types throughout the world. Higher morbidity in Asian countries is reported due to f...
作者:Maissa Yacuob Salem , Nagiba Yehia Hassan , Yasmin Mohamed Fayez ...
来源:[J].Current Pharmaceutical Analysis(IF 1.333), 2019, Vol.16 (1), pp.64-84Bentham
摘要:Background: Hydrochlorothiazide (HCTZ) is potent diuretic that is used alone or in combinationwith other drugs such as labetalol (Lab) (mixtures Ι) or nebivolol (Neb) (mixtures ΙΙ) to controlmoderate to sever hypertension.
作者:Rodolfo Ortigara , Martin Steppe , Cassia Virginia Garcia
来源:[J].Current Pharmaceutical Analysis(IF 1.333), 2019, Vol.16 (1), pp.55-63Bentham
摘要:Background: Ambrisentan is a drug used to treat the pulmonary arterial hypertension symptoms,commercialized as coated tablets. Drug quality control is an essential part for the developmentand release of drugs for consumption; however, there are few studies related to the proposit...
作者:Yan Cheng , Kuntian Lan , Xiaoxia Yang ...
来源:[J].Current Proteomics(IF 0.828), 2019, Vol.17 (1), pp.23-29Bentham
摘要:Background: Cervical cancer arises from the cervix and it is the 3rd most diagnosed malignancy and a foremost cause of cancer-related death in females. On the other hand, the expressions of EGFR and p53 are two important proteins observed in various studies on cervical cancer.
作者:Farzane Kargar , Mojtaba Mortazavi , Masoud Torkzadeh-Mahani ...
来源:[J].Current Proteomics(IF 0.828), 2019, Vol.17 (1), pp.30-39Bentham
摘要:Background: The firefly luciferase enzyme is widely used in protein engineering and diverse areas of biotechnology, but the main problem with this enzyme is low-temperature stability. Previous reports indicated that surface areas of thermostable proteins are rich in arginine, whi...
作者:Mateus Araújo Castro e Souza , Naialy Fernandes Araújo Reis , Larissa de Souza Batista ...
来源:[J].Current Pharmaceutical Analysis(IF 1.333), 2019, Vol.16 (1), pp.5-11Bentham
摘要:Introduction: Malaria, an infectious disease caused by protozoa of the genus Plasmodium, ishighly prevalent in the Brazilian Amazon. Chloroquine is the first-choice drug for the treatment of malariacaused by P. vivax and P. malariae. The humid and hot climate characteristic of th...
作者:Ibrahim Aljuffali , Fahad Almarri , A F M Motiur Rahman ...
来源:[J].Current Pharmaceutical Analysis(IF 1.333), 2019, Vol.16 (1), pp.100-109Bentham
摘要:Background: The purpose of the current study was to develop a selective, precise, fast economicaland advanced reverse phase ultra-high-performance liquid chromatography (UHPLC UV)method and validate it for the simultaneous estimation of cholecalciferol and its analogue 25-hydroxy...
作者:Nila Mary Varghese , Venkatachalam Senthil , Sajan Jose ...
来源:[J].Current Pharmaceutical Analysis(IF 1.333), 2019, Vol.16 (1), pp.12-23Bentham
摘要:Objective: A simple, accurate and economical Reverse Phase- High Performance LiquidChromatographic method has been developed for the simultaneous quantitative estimation of two antiretroviral drugs, Etravirine and Elvitegravir in nanoparticulate formulations for the first time. T...
作者:Ajit Anerao , Vishal Solase , Thaksen Gadhave ...
来源:[J].Current Pharmaceutical Analysis(IF 1.333), 2019, Vol.16 (1), pp.110-116Bentham
摘要:Background: Schiff base is an advanced key starting material of Sertraline hydrochloride.Schiff base is synthesized using two raw materials 1-Naphthol and 1,2-Dichlorobenzene which are potentiallygenotoxic impurities.

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×